Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow, 14 October 2026 (Including F&O)

  • October 13, 2026
  • Posted by: Kunal Singla
  • Category: Uncategorized
No Comments
Nifty Pharma Prediction for Tomorrow, 14 October 2026 (Including F&O)

Nifty Pharma closed at 26,075.00, down 0.01%. Nifty 50 rose 1.60%. India VIX fell 7.41% to 14.12. Next session is tomorrow, Wednesday 14 October.

Quick Answer

The nifty pharma prediction for tomorrow is neutral for Wednesday, 14 October 2026. Nifty Pharma was little changed at 26,075.00 on Tuesday, the only sector index in our set not to gain, as the Nifty 50 rose 1.60 percent. It had risen on Friday and Monday.

This nifty pharma prediction for tomorrow follows a Tuesday, 13 October 2026 session in which the Nifty Pharma index was little changed at 26,075.00, the only sector index we track not to gain on a day the Nifty 50 rose 1.60 percent.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are tracking sector-specific triggers and F&O positioning ahead of the session tomorrow, which falls on Wednesday, 14 October 2026.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Tuesday Told Us
  • Nifty Pharma Prediction for Tomorrow: Key Levels
  • Key Drivers for Tomorrow
  • Stocks and Triggers to Watch in the Nifty Pharma Space
  • How Tuesday’s Broader Session Unfolded
  • Analyst View for Tomorrow
  • Why This Is Written for Tomorrow
  • Risks to This Prediction
  • Conclusion
  • Frequently Asked Questions
    • What is the nifty pharma prediction for tomorrow?
    • Why is this a prediction for tomorrow, 14 October 2026?
    • Why was Nifty Pharma flat on Tuesday?
    • What are the key levels for Nifty Pharma tomorrow?
    • Is this a buy or sell call?

What Tuesday Told Us

  • Nifty Pharma closed at 26,075.00, down 0.01 percent on 13 October 2026.
  • The broader Nifty 50 rose 1.60 percent.
  • India VIX fell 7.41 percent to 14.12.

Nifty Pharma Prediction for Tomorrow: Key Levels

Nifty Pharma traded between 25,773.75 and 26,079.00 on Tuesday, against a previous close of 26,078.85, and settled at 26,075.00. On the downside, 25,773.75 is the first reference level to watch if the day’s move is tested. On the upside, 26,078.85 and 26,079.00 mark the nearest resistance. Univest’s analysts treat these as reference points drawn from Tuesday’s trading range, not as targets.

Trend Support Resistance
Neutral 25,773.75 26,078.85, 26,079.00

The table uses Tuesday’s high, low and previous close for Nifty Pharma.

Key Drivers for Tomorrow

  • Nifty Pharma was little changed at 26,075.00, with a high of 26,079.00 and a low of 25,773.75.
  • The index recovered from an intraday low of 25,773.75 to close flat, a wide recovery.
  • US generic pricing and regulatory updates are the sector’s usual triggers.

Anyone following this nifty pharma prediction for tomorrow should keep the next session’s opening range in view before reading too much into early moves.

Stocks and Triggers to Watch in the Nifty Pharma Space

Nifty Pharma is a defensive group that tends to lag in sharp risk-on rallies. A flat close after a strong recovery from the low shows buyers defended the level.

In the F&O segment, Univest’s analysts suggest watching India VIX and open-interest changes near the support and resistance levels above before drawing conclusions. India VIX fell to 14.12 on Tuesday, which usually supports calmer option pricing, though a jump would widen expected ranges.

Univest’s analysts suggest treating this nifty pharma prediction for tomorrow as a preparation note for Wednesday, 14 October 2026, rather than a signal that changes overnight.

These are educational views, not buy calls, and each should be checked against your own risk plan before acting.

How Tuesday’s Broader Session Unfolded

The Nifty 50 closed at 22,721.95, up 1.60 percent, with a high of 22,721.95 and a low of 22,288.45. The Sensex closed at 73,033.78, up 1.54 percent, and the Bank Nifty closed at 55,481.05, up 1.03 percent. India VIX, the market’s fear gauge, fell 7.41 percent to 14.12, which usually points to calmer expected swings in the near term. The Tuesday rise followed a fall on Monday, so part of the move may be a rebound rather than a fresh uptrend. The trigger for the broad gain was not independently confirmed.

This nifty pharma prediction for tomorrow will be most useful when read alongside the support and resistance table above.

Analyst View for Tomorrow

Kunal Singla suggests that the sector can stay steady above 25,774, Tuesday’s low, while rotation favours cyclicals.

Ankit Jaiswal flags that US pricing trends and regulatory headlines matter more than daily market direction here.

A fair reading of this nifty pharma prediction for tomorrow is that Tuesday’s data sets the context, while Wednesday’s first hour decides how much of it carries forward.

Why This Is Written for Tomorrow

This nifty pharma prediction for tomorrow is written after the close on Tuesday, 13 October 2026, using Tuesday’s closing data, for the next trading session on Wednesday, 14 October 2026. Treat it as a briefing to prepare for that session, not a live call that updates through the evening.

Track the Nifty Pharma Space on Univest Screeners

Readers comparing views should note that this nifty pharma prediction for tomorrow draws only on Tuesday’s closing numbers and the factors listed here.

Risks to This Prediction

  • A rise in the rupee could trim export earnings for pharma makers.
  • US regulatory action can hurt individual stocks.
  • Money rotating into IT and cyclicals could keep pharma lagging.

As with any nifty pharma prediction for tomorrow, the opening minutes of Wednesday’s trade will confirm or challenge the levels discussed here.

The nifty pharma prediction for tomorrow also depends on India VIX, so a fresh rise in volatility would weaken the case made here.

Download the Univest iOS App or Univest Android App to get daily market recommendations and insightful research pieces.

Conclusion

The nifty pharma prediction for tomorrow leans neutral into 14 October 2026, with broader Nifty 50 direction and India VIX as the key variables to track. Ankit Jaiswal and Kunal Singla will revisit this view once Wednesday’s opening trade confirms direction.

For traders, this nifty pharma prediction for tomorrow is a framework for planning risk, with position size and stop levels left to the individual.

Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

Frequently Asked Questions

What is the nifty pharma prediction for tomorrow?

Ans. It is neutral for 14 October 2026, after Nifty Pharma closed at 26,075.00 on Tuesday, down 0.01 percent.

Why is this a prediction for tomorrow, 14 October 2026?

Ans. Because it is written after the close on Tuesday, 13 October 2026, for the next regular trading session on Wednesday, 14 October 2026.

Why was Nifty Pharma flat on Tuesday?

Ans. Nifty Pharma closed down 0.01 percent while the Nifty 50 rose 1.60 percent. The reason was not independently confirmed.

What are the key levels for Nifty Pharma tomorrow?

Ans. Tuesday’s low of 25,773.75 is the nearest support below the price, while the previous close of 26,078.85 and Tuesday’s high of 26,079.00 are the nearest resistance.

Is this a buy or sell call?

Ans. No. This is an educational outlook from Univest’s research team, not a buy or sell call. Traders should check any view against their own risk plan before acting.



Nifty Pharma
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply